Your browser doesn't support javascript.
loading
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study.
de Isla, Leopoldo Pérez; Vallejo-Vaz, Antonio J; Watts, Gerald F; Muñiz-Grijalvo, Ovidio; Alonso, Rodrigo; Diaz-Diaz, Jose L; Arroyo-Olivares, Raquel; Aguado, Rocio; Argueso, Rosa; Mauri, Marta; Romero, Manuel J; Álvarez-Baños, Pilar; Mañas, Dolores; Cepeda, José María; Gonzalez-Bustos, Pablo; Casañas, Marta; Michan, Alfredo; Muñoz-Torrero, Juan F Sánchez; Faedo, Ceferino; Barba, Miguel A; Dieguez, Marta; de Andrés, Raimundo; Hernandez, Antonio M; Gonzalez-Estrada, Aurora; Padró, Teresa; Fuentes, Francisco; Badimon, Lina; Mata, Pedro.
Afiliación
  • de Isla LP; Cardiology Department, Hospital Clínico San Carlos, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Fundación Hipercolesterolemia Familiar, Madrid, Spain. Electronic address: leopisla@hotmail.com.
  • Vallejo-Vaz AJ; Department of Medicine, Faculty of Medicine, University of Seville, Seville, Spain; Clinical Epidemiology and Vascular Risk, Instituto de Biomedicina de Sevilla (IBiS), IBiS/Hospital Universitario Virgen del Rocío/Universidad de Sevilla/CSIC, Seville, Spain; Centro de Investigación Biomédica en Red
  • Watts GF; School of Medicine, University of Western Australia, Perth, WA, Australia; Cardiometabolic Services, Departments of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, WA, Australia.
  • Muñiz-Grijalvo O; Clinical Epidemiology and Vascular Risk, Instituto de Biomedicina de Sevilla (IBiS), IBiS/Hospital Universitario Virgen del Rocío/Universidad de Sevilla/CSIC, Seville, Spain; Department of Internal Medicine, Hospital Virgen del Rocío, Seville, Spain.
  • Alonso R; Fundación Hipercolesterolemia Familiar, Madrid, Spain; Center for Advanced Metabolic Medicine and Nutrition, Santiago, Chile.
  • Diaz-Diaz JL; Department of Internal Medicine, Hospital Abente y Lago, A Coruña, Spain.
  • Arroyo-Olivares R; Fundación Hipercolesterolemia Familiar, Madrid, Spain.
  • Aguado R; Department of Endocrinology, Hospital General de Leon, Leon, Spain.
  • Argueso R; Department of Endocrinology, Hospital Universitario Lucus Augusti, Lugo, Spain.
  • Mauri M; Department of Internal Medicine, Hospital de Terrassa, Terrassa, Spain.
  • Romero MJ; Department of Internal Medicine, Hospital Infanta Elena, Huelva, Spain.
  • Álvarez-Baños P; Department of Endocrinology, Hospital Universitario de Burgos, Burgos, Spain.
  • Mañas D; Department of Internal Medicine, Hospital Universitario de Ciudad Real, Ciudad Real, Spain.
  • Cepeda JM; Department of Internal Medicine, Hospital Comarcal Vega Baja, Orihuela, Spain.
  • Gonzalez-Bustos P; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Casañas M; Department of Internal Medicine, Hospital de San Pedro, Logroño, Spain.
  • Michan A; Department of Internal Medicine, Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain.
  • Muñoz-Torrero JFS; Department of Internal Medicine, Hospital San Pedro de Alcántara, Cáceres, Spain.
  • Faedo C; Department of Endocrinology, Hospital Central de Asturias, Oviedo, Spain.
  • Barba MA; Department of Internal Medicine, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
  • Dieguez M; Department of Endocrinology, Hospital de Cabueñes, Gijón, Spain.
  • de Andrés R; Department of Internal Medicine, Fundación Jiménez Díaz, Madrid, Spain.
  • Hernandez AM; Department of Endocrinology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Gonzalez-Estrada A; Clinical Epidemiology and Vascular Risk, Instituto de Biomedicina de Sevilla (IBiS), IBiS/Hospital Universitario Virgen del Rocío/Universidad de Sevilla/CSIC, Seville, Spain; Department of Internal Medicine, Hospital Virgen del Rocío, Seville, Spain.
  • Padró T; Research Institute-Hospital de la Santa Creu i Sant Pau, IIBSant Pau, CiberCV, Barcelona, Spain.
  • Fuentes F; Lipids and Atherosclerosis Unit, CIBERObn, IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain.
  • Badimon L; Research Institute-Hospital de la Santa Creu i Sant Pau, IIBSant Pau, CiberCV, Barcelona, Spain.
  • Mata P; Fundación Hipercolesterolemia Familiar, Madrid, Spain. Electronic address: pmata@colesterolfamiliar.org.
Lancet Diabetes Endocrinol ; 12(9): 643-652, 2024 Sep.
Article en En | MEDLINE | ID: mdl-39098315
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Hiperlipoproteinemia Tipo II Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Hiperlipoproteinemia Tipo II Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2024 Tipo del documento: Article